Ultragenyx’s Rare Bootcamp gives families a roadmap to help drive research and develop new treatments for rare diseases.

Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, shortly after authorizing the first. The latest approval, for Toronto-based Apotex, makes Canada ...

Health Canada has approved a second generic version of semaglutide, the active ingredient in Ozempic, Wegovy and Mounjaro, from Canadian firm Apotex. This follows the country’s first generic approval ...

This article provides an overview of the regulatory regime and associated intellectual property rights for veterinary drug ...

The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...

In a major development that would dramatically cut the cost of a popular but pricey weight-loss drug, the Food and Drug Administration has given Apotex Corp. tentative approval to market the first ...

In the wake of Novo Nordisk losing semaglutide patent protection in India, generic drug companies are releasing lower cost generics. Dr. Reddy’s has released semaglutide for treating diabetes at ...

With 90% of prescriptions in the US filled for generic drugs, there is growing concern that supplies of the medications could be in short supply due to the ongoing situation in the Strait of Hormuz, a ...

To learn more about the CNBC CFO Council, visit cnbccouncils.com/cfo Nearly half of U.S. generic prescriptions originate in India, which relies on the Strait of ...

Tensions in the Strait of Hormuz are raising alarms about the stability of global pharmaceutical supply chains, with potential implications for the U.S. generic drug market, which relies heavily on ...

In September, the Trump administration took what it called “bold actions” on autism that included touting the generic drug leucovorin as a promising treatment. In a news release, Marty Makary, ...